China Pharma Holdings (CPHI) Gross Margin Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 | 1,729.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,100.00 |
| Dec 31, 2025 | 2,646.00 |
| Sep 30, 2025 | 3,935.00 |
| Jun 30, 2025 | 10,130.00 |
| Mar 31, 2025 | 920.00 |
| Dec 31, 2024 | -1,048.00 |
| Sep 30, 2024 | -3,430.00 |
| Jun 30, 2024 | -9,642.00 |
| Mar 31, 2024 | -3,025.00 |
| Dec 31, 2023 | -514.00 |
| Sep 30, 2023 | -592.00 |
| Jun 30, 2023 | 86.00 |
| Mar 31, 2023 | 1,964.00 |
| Dec 31, 2022 | -899.00 |
| Sep 30, 2022 | 797.00 |
| Jun 30, 2022 | -1,716.00 |
| Mar 31, 2022 | -2,213.00 |
| Dec 31, 2021 | -871.00 |
| Sep 30, 2021 | -1,695.00 |
| Jun 30, 2021 | -2,755.00 |